drugset
drugset / Trial / NCT00791336

Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer

NCT00791336 ↗

Phase 2 Terminated 1 enrolled University of Iowa
NaSingle-groupOpen-labelTreatment

Summary

This study combines nelfinavir (NFV) with radiation therapy and chemotherapy as a treatment for non-small cell lung cancer (NSCLC) who are considered candidates for pre-operative treatment.

Timeline

Start
2008-08
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nelfinavir Other / unclassified 1250 mg —

Indications

non-small cell lung carcinoma